Share General Information
Paliperidone Palmitate is an atypical antipsychotic, indicated for the treatment of schizophrenia and schizoaffective disorder in its finished dosage. Paliperidone is the primary active metabolite of risperidone. The mechanism of action is likely to be similar to risperidone. The manufacturing of paliperidone palmitate involves combining paliperidone API, the active component, with palmitic acid to form the palmitate ester. Paliperidone form of palmitate ester is formulated prolonged release suspension and acts as long lasting Paliperidone into the bloodstream during of time 1, 3 and 6 months.
About the API
-
Japan DMF
-
Korea DMF
-
US DMF
The information detailed herein, including that with regard to active pharmaceutical ingredients , their use in treatments and possible mechanism(s) of action, was all obtained from public sources.
For more information on our services and products – including product suitability, intended uses and current availability – please contact Teva api Customer Service. CAS Registry Number is a Registered Trademark of the American Chemical Society. This webpage and any reference to the above product is to be read within the meaning and terms of the Legal Notes.
